Valor202020212022202320242025TTMDespesas comerciais, gerais e administrativas8.85 B10.54 B7.78 B8.66 B8.51 B8.1 B8.1 BPesquisa e desenvolvimento———————Lucro operacional-5.04 B2.04 B4.38 B3.91 B4.42 B6.21 B6.21 BLucro não operacional, total223 M259 M497 M132 M202 M236 M236 MDespesa com juros, líquida de juros capitalizados217 M178 M248 M252 M265 M247 M247 MReceitas não operacionais, líquidas das despesas com juros-24 M-22 M-30 M-154 M240 M-55 M260 MReceitas/despesas incomuns30 M103 M279 M34 M-38 M44 M—Lucro antes dos impostos-5.03 B1.93 B4.63 B3.79 B4.36 B6.2 B6.2 BParticipação no lucro48 M43 M5 M4 M9 M7 M—Impostos-695 M636 M905 M629 M878 M1.1 B1.1 BParticipação de minoritários199 M173 M162 M158 M186 M337 M337 MOutras receitas/despesas após impostos-188 M-501 M-298 M-233 M-424 M-302 M-302 MLucro líquido antes das operações descontinuadas-4.54 B1.12 B3.56 B3 B3.29 B4.76 B4.76 BOperações descontinuadas-1 M-5 M-3 M00——Lucro líquido-4.54 B1.11 B3.56 B3 B3.29 B4.76 B4.76 BAjuste de diluição———————Dividendos de ações preferenciais———————Lucro líquido diluído disponível aos acionistas-4.54 B1.11 B3.56 B3 B3.29 B4.76 B4.76 BLucro básico por ação-28.267.3225.2322.5425.8638.5538.55Lucro diluído por ação-28.267.2325.0322.3925.7238.3838.38Número médio de ações básicas160.6 M152.3 M141.1 M133.2 M127.4 M123.6 M—Ações diluídas160.6 M154.1 M142.2 M134.1 M128.1 M124.1 M—EBITDA-4.7 B2.35 B4.65 B4.19 B4.69 B6.5 B6.94 BEBIT-5.04 B2.04 B4.38 B3.91 B4.42 B6.21 B6.21 BCusto da receita226.08 B250.84 B264.35 B296.12 B345.73 B388.88 B388.88 BOutros componentes do custo———————Amortização e depreciação (fluxo de caixa)344 M312 M272 M279 M272 M287 M729 M
McKesson Corporation Common Stock
McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK".
McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States.
Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses.